Organovo Holdings

About:

Organovo develops a range of tissue and disease models for medical research and therapeutic applications.

Website: http://www.organovo.com/

Twitter/X: Organovo/

Top Investors: SternAegis, Spencer Trask & Co, Eric Del Balso, Michael Brams

Description:

Organovo is focused on delivering breakthrough three-dimensional biology capabilities to create tissue on demand for research and surgical applications. As the first company with a three-dimensional tissue technology that works across tissue types, they are meeting the promise of regenerative medicine to fill unmet medical needs.

Total Funding Amount:

$118M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

San Diego, California, United States

Founded Date:

2007-01-01

Contact Email:

info(AT)organovo.com

Founders:

Andras Forgacs, Gabor Forgacs

Number of Employees:

51-100

Last Funding Date:

2024-05-08

IPO Status:

Public

Industries:

© 2025 bioDAO.ai